Institutional investors purchased a net $767.1 thousand shares of AVEO during the quarter ended September 2016 and now own 21.08% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
683 CAPITAL MANAGEMENT LLC Bought 1.0 Million shares of Aveo Pharmaceuticals Inc